Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
63 participants
OBSERVATIONAL
2007-02-28
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The TearAD Study: Tear Biomarkers for Alzheimer's Disease (AD) Screening and Diagnosis
NCT05655793
Characterization of Novel Lipoprotein Properties Associated With an Increased Risk to Develop Atherosclerosis
NCT04487223
Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
NCT02096523
Follow up of Nasolacrimal Intubation in Adults
NCT00706251
Study of the Development of Human Immune System of Newborns by Antigen Chips
NCT00843648
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Subject
Subjects receiving eye examination
Eye Examination
Subjects receiving eye examination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eye Examination
Subjects receiving eye examination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to cooperate with tear sample collection
* provide written informed consent
Exclusion Criteria
* refusal to sign sudy consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Malik Y. Kahook, MD
Role: PRINCIPAL_INVESTIGATOR
Rocky Mountain Lions Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rocky Mountain Lions Eye Institute
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
06-0862
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.